Total Payments
$1.0M
2024 Payments
$191,157
Companies
28
Transactions
597
Payment Breakdown by Category
Consulting$411,846 (40.0%)
Other$381,055 (37.0%)
Travel$197,490 (19.2%)
Research$21,437 (2.1%)
Food & Beverage$16,878 (1.6%)
Gifts$154.45 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $411,846 | 108 | 40.0% |
| Honoraria | $309,754 | 72 | 30.1% |
| Travel and Lodging | $197,490 | 191 | 19.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $71,302 | 25 | 6.9% |
| Unspecified | $21,437 | 7 | 2.1% |
| Food and Beverage | $16,878 | 191 | 1.6% |
| Gift | $154.45 | 3 | 0.0% |
Payments by Type
General
$1.0M
590 transactions
Research
$21,437
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| H. Lundbeck A S | $354,030 | 130 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $159,630 | 68 | $0 (2024) |
| Alkermes, Inc. | $70,808 | 48 | $0 (2024) |
| Sumitomo Dainippon Pharma Co., Ltd. | $63,252 | 52 | $0 (2021) |
| Sumitomo Pharma Co., Ltd. | $59,908 | 43 | $0 (2024) |
| Otsuka Pharmaceutical Co., Ltd. | $43,083 | 27 | $0 (2023) |
| Aurobindo Pharma USA, Inc. | $40,579 | 7 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $34,318 | 25 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $26,242 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $23,384 | 25 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $191,157 | 127 | Teva Pharmaceuticals USA, Inc. ($47,188) |
| 2023 | $167,776 | 100 | H. Lundbeck A S ($59,745) |
| 2022 | $140,318 | 79 | Teva Pharmaceuticals USA, Inc. ($36,780) |
| 2021 | $121,534 | 40 | H. Lundbeck A S ($37,185) |
| 2020 | $88,292 | 51 | H. Lundbeck A S ($22,517) |
| 2019 | $80,958 | 57 | H. Lundbeck A S ($33,944) |
| 2018 | $90,078 | 68 | H. Lundbeck A S ($42,210) |
| 2017 | $148,746 | 75 | H. Lundbeck A S ($123,790) |
All Payment Transactions
597 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $689.62 | General |
| Category: Neurology | ||||||
| 12/23/2024 | Aurobindo Pharma USA, Inc. | Clozapine (Drug) | Consulting Fee | Cash or cash equivalent | $39,805.35 | General |
| Category: Psychiatry | ||||||
| 12/23/2024 | Mylan Inc. | CLOZAPINE (Drug) | Consulting Fee | Cash or cash equivalent | $8,233.07 | General |
| Category: Antipsychotics | ||||||
| 12/23/2024 | Aurobindo Pharma USA, Inc. | Clozapine (Drug) | Travel and Lodging | Cash or cash equivalent | $50.81 | General |
| Category: Psychiatry | ||||||
| 12/23/2024 | Mylan Inc. | CLOZAPINE (Drug) | Travel and Lodging | Cash or cash equivalent | $21.74 | General |
| Category: Antipsychotics | ||||||
| 12/23/2024 | Aurobindo Pharma USA, Inc. | Clozapine (Drug) | Travel and Lodging | Cash or cash equivalent | $20.97 | General |
| Category: Psychiatry | ||||||
| 12/23/2024 | Mylan Inc. | CLOZAPINE (Drug) | Travel and Lodging | Cash or cash equivalent | $10.65 | General |
| Category: Antipsychotics | ||||||
| 12/23/2024 | Mylan Inc. | CLOZAPINE (Drug) | Travel and Lodging | Cash or cash equivalent | $10.33 | General |
| Category: Antipsychotics | ||||||
| 12/23/2024 | Mylan Inc. | CLOZAPINE (Drug) | Travel and Lodging | Cash or cash equivalent | $10.21 | General |
| Category: Antipsychotics | ||||||
| 12/23/2024 | Mylan Inc. | CLOZAPINE (Drug) | Travel and Lodging | Cash or cash equivalent | $9.60 | General |
| Category: Antipsychotics | ||||||
| 12/23/2024 | Mylan Inc. | CLOZAPINE (Drug) | Travel and Lodging | Cash or cash equivalent | $9.27 | General |
| Category: Antipsychotics | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $35.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,005.00 | General |
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $140.00 | General |
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 12/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Travel and Lodging | In-kind items and services | $645.61 | General |
| Category: CNS | ||||||
| 12/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $420.75 | General |
| Category: CNS | ||||||
| 12/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $43.99 | General |
| Category: CNS | ||||||
| 11/29/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $4,837.00 | General |
| 11/20/2024 | Mylan Inc. | CLOZAPINE (Drug) | Travel and Lodging | In-kind items and services | $45.95 | General |
| Category: Antipsychotics | ||||||
| 11/19/2024 | Mylan Inc. | CLOZAPINE (Drug) | Travel and Lodging | In-kind items and services | $81.84 | General |
| Category: Antipsychotics | ||||||
| 11/19/2024 | Mylan Inc. | CLOZAPINE (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Antipsychotics | ||||||
| 11/18/2024 | Mylan Inc. | CLOZAPINE (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Antipsychotics | ||||||
| 11/18/2024 | Mylan Inc. | CLOZAPINE (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Antipsychotics | ||||||
| 11/18/2024 | Mylan Inc. | CLOZAPINE (Drug) | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: Antipsychotics | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia (DayBreak) | H. Lundbeck A S | $9,200 | 1 |
| Publications Support | Teva Pharmaceuticals USA, Inc. | $4,998 | 1 |
| Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD | Otsuka Pharmaceutical Development & Commercialization, Inc. | $77.44 | 1 |
About John Kane
John Kane is a Psychiatry healthcare provider based in Glen Oaks, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1164556429.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Kane has received a total of $1.0M in payments from pharmaceutical and medical device companies, with $191,157 received in 2024. These payments were reported across 597 transactions from 28 companies. The most common payment nature is "Consulting Fee" ($411,846).
Ad
Practice Information
- Specialty Psychiatry
- Location Glen Oaks, NY
- Active Since 03/16/2007
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1164556429
Products in Payments
- ABILIFY MAINTENA (Drug) $315,174
- Latuda (Drug) $122,112
- Clozapine (Drug) $40,579
- REXULTI (Drug) $37,839
- ARISTADA (Drug) $23,087
- INVEGA SUSTENNA (Drug) $20,635
- Non-Covered Product (Drug) $17,784
- ABILIFY MYCITE (Drug) $17,690
- AUSTEDO (Drug) $14,257
- PERSERIS (Drug) $13,215
- TRINTELLIX (Drug) $12,308
- UZEDY (Drug) $11,952
- Lu AF35700 (Drug) $9,200
- CLOZAPINE (Drug) $9,007
- LYBALVI (Drug) $8,747
- NUPLAZID (Drug) $8,703
- COBENFY (Drug) $5,981
- SD809-TD (Drug) $5,513
- INGREZZA (Drug) $3,612
- MK-8189 (Drug) $2,250
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Glen Oaks
Christoph Correll, Md, MD
Psychiatry — Payments: $1.5M
Psychiatry $1.5M
Youssef Hassoun, Md, MD
Psychiatry — Payments: $392,961
Psychiatry $392,961
Jose Rubio Lorente, M.d, M.D
Psychiatry — Payments: $98,495
Psychiatry $98,495
Dr. Delbert Robinson, M.d, M.D
Psychiatry — Payments: $81,352
Psychiatry $81,352
Jeremy Koppel, Md, MD
Psychiatry — Payments: $61,314
Psychiatry $61,314
Dr. Kristina Deligiannidis, Md, MD
Psychiatry — Payments: $20,811
Psychiatry $20,811